NEW YORK, Feb 26 (Reuters) - Eli Lilly and Co. said on Monday that the U.S. Food and Drug Administration has added treatment of generalized anxiety disorder to the approved uses for the drugmaker's ...

Findings seen in older adults with diabetic neuropathy, postherpetic neuralgia, or fibromyalgia. (HealthDay News) — Incident use of gabapentin is not associated with an increase in fall-related ...

Do you need help with the cost of Cymbalta? Cymbalta was developed by Eli Lilly and Company for use in the treatment of depression, generalized anxiety disorder, major depressive disorder, ...

A nationwide recall of more than 233,000 bottles of duloxetine, an anti-depressant, has been announced by the Food and Drug Administration for possibly containing a chemical increasing the risk of ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary recall ...

More than 233,000 bottles of the antidepressant duloxetine have been recalled because of a chemical that contains the risk of cancer, public health officials said. The U.S. Food and Drug ...

Duloxetine is also used to treat pain and tingling caused by diabetic neuropathy damage to nerves that can develop in people who have diabetes and fibromyalgia a long-lasting condition that may cause ...

Please provide your email address to receive an email when new articles are posted on . Patients with central sensitization who received duloxetine slept 1.4 more hours on average in the first week ...

The analytic cohort included 57,086 older adults initiating treatment with gabapentin or duloxetine. HealthDay News — Incident use of gabapentin is not associated with an increase in fall-related ...

The U.S. Food and Drug Administration announced a Class II recall for more than 7,100 bottles of Duloxetine — a generic antidepressant for Cymbalta — due to a cancerous chemical. A voluntary recall ...